The objective of this contract is to understand the human host-pathogen response generated by infection or vaccination with respiratory bacteria and/or viruses. This information is needed in order to develop effective vaccination strategies against respiratory pathogens. To accomplish the objectives of this contract, the contractor will perform detailed immune studies in volunteers, following vaccine administration and, when appropriate pathogen challenge. Microbiologic and immunologic interactions between respiratory virus and bacteria will also be extensively evaluated, as will strategies for the early diagnosis of pneumonia. Further efforts will be made through iterative methodology to maximize that protective aspect of the immune response through the use of various adjuvants, delivery systems, dosing schedules or other methods. It is further intended that the contractor will interact effectively and frequently with a second contractor working on equivalent studies of enteric pathogens. It is anticipated that synergistic effects will be achieved by these two groups in the furthering of our understanding of the human mucosal and systemic immune response. Such a result will likely benefit studies of diseases other than those associated with the respiratory or digestive systems. It is anticipated that these studies will lead to more effective vaccine strategies against a large number of infectious diseases.

Project Start
1996-01-22
Project End
2003-01-21
Budget Start
1999-09-29
Budget End
2001-01-21
Support Year
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Huaman, Moises A; Henson, David; Ticona, Eduardo et al. (2015) Tuberculosis and Cardiovascular Disease: Linking the Epidemics. Trop Dis Travel Med Vaccines 1:
Yang, Chin-Fen; Wang, Chiaoyin K; Tollefson, Sharon J et al. (2013) Human metapneumovirus G protein is highly conserved within but not between genetic lineages. Arch Virol 158:1245-52
Fiske, Christina T; Griffin, Marie R; Mitchel, Ed et al. (2012) Accuracy of pharmacy and coded-diagnosis information in identifying tuberculosis in patients with rheumatoid arthritis. Pharmacoepidemiol Drug Saf 21:666-9
Zhu, Jie; Bandi, Venkata; Qiu, Shengyang et al. (2012) Cysteinyl leukotriene 1 receptor expression associated with bronchial inflammation in severe exacerbations of COPD. Chest 142:347-357
Atmar, Robert L; Piedra, Pedro A; Patel, Shital M et al. (2012) Picornavirus, the most common respiratory virus causing infection among patients of all ages hospitalized with acute respiratory illness. J Clin Microbiol 50:506-8
Koethe, John R; Jenkins, Cathy A; Shepherd, Bryan E et al. (2011) An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy. Clin Infect Dis 53:952-60
Singh, Manisha; Lee, Seung-Hyo; Porter, Paul et al. (2010) Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 125:1369-1378.e2
Laham, Federico R; Trott, Amanda A; Bennett, Berkeley L et al. (2010) LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity. Pediatrics 125:e225-33
Yang, Chin-Fen; Wang, Chiaoyin K; Tollefson, Sharon J et al. (2009) Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol J 6:138
Feng, JingQi; Gulati, Upma; Zhang, Xiaoju et al. (2009) Antibody quantity versus quality after influenza vaccination. Vaccine 27:6358-62

Showing the most recent 10 out of 45 publications